Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collatamp G versus levofloxacin for mildly infected diabetic lower-extremity skin ulcers
2008-000207-28Phase 2Terminated
- Sponsor
- Innocoll
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in diabetic foot ulcer (DFU) and Cutaneous ulcer comparing Collatamp G plus standard of care with Tavanic plus standard of care (2 arms). Primary endpoint: Clinical cure at final study visit. Started Mar 2008; status: terminated.
02
Drugs
gentamicin collagen spongelevofloxacin
03
Conditions
diabetic foot ulcer (DFU)Cutaneous ulcer
Beyond the preview
Go deeper on 2008-000207-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000207-28.